Assistant Professor, Medicine-Massachusetts General Hospital, Harvard Medical School

Oncology

David Ting works in the field of Oncology. He studied medicine at Harvard Medical School. Harvard Medical School is a one of the best medicals schools. Harvard Medical School is ranked 1/12 in Research/PrimaryCare. Doctor David T. Ting, MD is a published doctor. He published 26 publications, including: 'Intra-pancreatic Distal Bile Duct Carcinoma is Morphologically, Genetically, and Clinically Distinct from Pancreatic Ductal Adenocarcinoma.' He accepts Medicare payments and is registered with Medicare.gov.

Publications

---

• Branched-chain in situ hybridization for κ and λ light chains: A powerful ancillary technique for determining B-cell clonality in cytology samples.
• Pericentromeric satellite repeat expansions through RNA-derived DNA intermediates in cancer.
• Distinguishing the immunostimulatory properties of noncoding RNAs expressed in cancer cells.
• Erratum to: The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology.
• MAPK7 regulates EMT Features and Modulates the Generation of CTCs.
• Microsatellite instability in gallbladder carcinoma.
• Branched chain in situ hybridization for albumin as a marker of hepatocellular differentiation: evaluation of manual and automated in situ hybridization platforms.
• Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer.
• The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology.
• EWS-FLI1 Utilizes Divergent Chromatin Remodeling Mechanisms to Directly Activate or Repress Enhancer Elements in Ewing Sarcoma.
• Single-Cell RNA Sequencing Identifies Extracellular Matrix Gene Expression by Pancreatic Circulating Tumor Cells.
• Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis.
• Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility.
• The wide gulf between stage III and stage IV colon cancer.
• Isolation and Molecular Characterization of Circulating Melanoma Cells.
• Dynamic Chromatin Modification Sustains Epithelial-Mesenchymal Transition following Inducible Expression of Snail-1.
• Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells.
• Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition.
• Androgen Receptor Signaling in Circulating Tumor Cells as a Marker of Hormonally Responsive Prostate Cancer.
• RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis.
• Aberrant overexpression of satellite repeats in pancreatic and other epithelial cancers.
• Amplification-free digital gene expression profiling from minute cell quantities.
• Inducible transgene expression in mouse stem cells.
• BRCA1 haploinsufficiency for replication stress suppression in primary cells.
• Intra-pancreatic Distal Bile Duct Carcinoma is Morphologically, Genetically, and Clinically Distinct from Pancreatic Ductal Adenocarcinoma.

Schools

---

• Harvard Medical School

• Massachusetts General Hospital

• Dana Farber Cancer Institute

Doctors Specialties

---

• Internal Medicine
• Pediatrics
• Oncology

Accepted Insurances

---

Education

---

• Brigham and Women's Hospital
• Massachusetts General Hospital
• Harvard Medical School

Hospital

---

• Massachusetts General Hospital

Drug Facts

---

NPI NUMBER		1053388108
NPPES Provider LastName		TING
NPPES Provider FirstName		DAVID
NPPES Provider ZIPCode		021142621
NPPES Provider State		MA
Specialty Description		Hematology/Oncology
Total Claim Count		23.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1053388108
Last Name Of The Provider	TING
First Name Of The Provider	DAVID
View All

Similar Doctors

---

	Dr. Andrew J. Aguirre, MD This Doctor is OpenDoctor Recommended.
	Dr. Eddy J. Chen, MD This Doctor is OpenDoctor Recommended.
	Dr. Michael S. Rabin, MD This Doctor is OpenDoctor Recommended.
	Dr. Elizabeth I. Buchbinder, MD This Doctor is OpenDoctor Recommended.
	Dr. Julian A. Mitton, MD
	Dr. Rebecca Eskin Berger, MD
	Dr. William P. Martin, MD
	Dr. Kathleen M. Finn, MD This Doctor is OpenDoctor Recommended.
	Dr. Albert G. Mulley Jr., MD This Doctor is OpenDoctor Recommended.
	Dr. Tian Gao, MD This Doctor is OpenDoctor Recommended.
	Dr. Keira A. Cohen, MD This Doctor is OpenDoctor Recommended.
	Dr. Thomas R. Mahoney, MD This Doctor is OpenDoctor Recommended.
	Dr. Paul M. Zusky, MD This Doctor is OpenDoctor Recommended.
	Dr. Leigh H. Simmons, MD This Doctor is OpenDoctor Recommended.
	Dr. Samantha J. Baras, MD
	Dr. Jheanelle L. McKay, MD
	Dr. Vi T. Nguyen, MD This Doctor is OpenDoctor Recommended.
	Dr. Christiana M. Russ, MD This Doctor is OpenDoctor Recommended.
	Dr. John K. Erban III, MD This Doctor is OpenDoctor Recommended.
	Dr. Jason Ackrivo, MD This Doctor is OpenDoctor Recommended.
	Dr. Damian D. Crawford, MD This Doctor is OpenDoctor Recommended.
	Dr. Kevin Chin, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog